Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 6Terminated 2Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 97Thoracic 48Gynecologic 27Breast 24CNS 21Genitourinary 10Head & Neck 6Other solid neoplasm 4Dermatologic 4Tumor-Agnostic 2Plasma cell 1Other neoplasm 1NET 1Lymphoid 1Endocrine 1

Conditions

Rectal Neoplasms 1Pancreatic Neoplasms 1Multiple Myeloma 1Liver Neoplasms 1Glioblastoma 1Gallbladder Neoplasms 1Colonic Neoplasms 1

Interventions

Dexamethasone 69Cyclophosphamide 43Bortezomib 40Lenalidomide 24Melphalan 22Thalidomide 19pomalidomide 17fludarabine 13daratumumab 13carfilzomib 10Doxorubicin 8Filgrastim 7Busulfan 6isatuximab 5Prednisone 5Peripheral Blood Stem Cell Transplantation 5Calcium Dobesilate 5Bendamustine Hydrochloride 5selinexor 4sargramostim 4fludarabine phosphate 4Surveys and Questionnaires 4Etoposide 4Clarithromycin 4liposomal doxorubicin 3ixazomib 3dexamethasone acetate 3Radiotherapy 3Neoadjuvant Therapy 3Mycophenolic Acid 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Bevacizumab × Plasma cell × Clear all
NCT03607643 2018-07-31

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Leaf Vertical Inc.

Phase 1/2 Unknown
160 enrolled
CNSGastrointestinalPlasma cell

Colonic Neoplasms, Gallbladder Neoplasms, Glioblastoma, Liver Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡